Honduras‑Guatemala medication supply challenges

In late July, Honduras’ Instituto Hondureño de Seguridad Social reported that its hospitals held about 86 % of needed medicines, with expectations to reach 90‑92 % by September thanks to a UN‑backed procurement effort. Doctors, however, warned that the health system still lacked sufficient beds and specialist staff and called for the appointment of a dedicated health minister.

A few days later, the focus shifted to a critical shortage of the opioid fentanyl in Honduras, which physicians said was caused by legal hurdles from both the previous and current administrations, jeopardising intensive‑care and surgical patients. In neighboring Guatemala, legislators worked to secure supplies for rare and catastrophic diseases, reporting that over 85 % of essential drugs were now available and announcing upgrades to a major teaching hospital’s operating rooms.

Together, the snapshots show a region where overall drug availability is improving, yet acute shortages of key medicines persist, prompting continued pressure on governments to address systemic health‑care gaps.